| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.082 | 0.2 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.2 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.068 | 0.2 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.2 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.075 | 0.2 |